CXCR4 and metastatic malignant neoplasm in the lymph nodes: Cabioglu et al. studied CXCR4 as a predictive marker for lymph node metastasis along with CCR7 [38], another chemokine receptor that has been shown to be expressed in breast cancer cells [7].